相似文献
1
Survival probability in ataxia telangiectasia.
Arch Dis Child. 2006 Jul;91(7):610-1. doi: 10.1136/adc.2006.094268.
2
Morbidity and mortality from ataxia-telangiectasia are associated with ATM genotype.
J Allergy Clin Immunol. 2011 Aug;128(2):382-9.e1. doi: 10.1016/j.jaci.2011.03.052. Epub 2011 Jun 12.
3
Cancer in homozygotes and heterozygotes of ataxia-telangiectasia and xeroderma pigmentosum in Britain.
Cancer Res. 1988 May 15;48(10):2929-32.
4
The critically ill patient with ataxia-telangiectasia: a case series.
Pediatr Crit Care Med. 2012 Mar;13(2):e84-90. doi: 10.1097/PCC.0b013e318219281c.
5
Cognitive phenotype in ataxia-telangiectasia.
Pediatr Neurol. 2014 Sep;51(3):297-310. doi: 10.1016/j.pediatrneurol.2014.04.027. Epub 2014 May 5.
6
Movement disorder in ataxia-telangiectasia: treatment with amantadine sulfate.
J Child Neurol. 2013 Feb;28(2):155-60. doi: 10.1177/0883073812441999. Epub 2012 May 1.
7
Real-life Wrist Movement Patterns Capture Motor Impairment in Individuals with Ataxia-Telangiectasia.
Cerebellum. 2023 Apr;22(2):261-271. doi: 10.1007/s12311-022-01385-5. Epub 2022 Mar 16.
8
Ataxia-telangiectasia in Iran: clinical and laboratory features of 104 patients.
Pediatr Neurol. 2007 Jul;37(1):21-8. doi: 10.1016/j.pediatrneurol.2007.03.002.
9
Immunodeficiency and infections in ataxia-telangiectasia.
J Pediatr. 2004 Apr;144(4):505-11. doi: 10.1016/j.jpeds.2003.12.046.
10
Phenotypic variations between affected siblings with ataxia-telangiectasia: ataxia-telangiectasia in Japan.
Int J Hematol. 2009 Nov;90(4):455-462. doi: 10.1007/s12185-009-0408-0. Epub 2009 Aug 25.
引用本文的文献
1
Accuracy and Reliability of At-home Quantification of Motor Impairments Using a Computer-based Pointing Task with Children with Ataxia-Telangiectasia.
ACM Trans Access Comput. 2023 Mar;16(1). doi: 10.1145/3581790. Epub 2023 Mar 28.
2
MRI and Biomarkers in Early Detection of Pulmonary Changes in Ataxia-Telangiectasia.
Med Sci Monit. 2025 Aug 14;31:e946570. doi: 10.12659/MSM.946570.
3
Nutritional status and metabolic alterations in patients with ataxia-telangiectasia.
Orphanet J Rare Dis. 2025 Jul 1;20(1):330. doi: 10.1186/s13023-025-03785-2.
4
Evaluation of T-cell repertoire by flow cytometric analysis in primary immunodeficiencies with DNA repair defects.
Scand J Immunol. 2025 Feb;101(2):e70003. doi: 10.1111/sji.70003.
5
An overview of proactive monitoring and management of respiratory issues in ataxia-telangiectasia in a specialist and shared care pediatric clinic.
Front Pediatr. 2024 Dec 23;12:1479620. doi: 10.3389/fped.2024.1479620. eCollection 2024.
6
Novel pathogenic ATM mutation with ataxia-telangiectasia in a Chinese family.
Front Genet. 2024 Nov 28;15:1491649. doi: 10.3389/fgene.2024.1491649. eCollection 2024.
7
Immune profiling and functional analysis of NK and T cells in ataxia telangiectasia.
Front Immunol. 2024 Aug 6;15:1377955. doi: 10.3389/fimmu.2024.1377955. eCollection 2024.
8
Case report: Compound heterozygous variants detected by next-generation sequencing in a Tunisian child with ataxia-telangiectasia.
Front Neurol. 2024 May 31;15:1344018. doi: 10.3389/fneur.2024.1344018. eCollection 2024.
9
Ataxia-telangiectasia in Latin America: clinical features, immunodeficiency, and mortality in a multicenter study.
Immunol Res. 2024 Aug;72(4):864-873. doi: 10.1007/s12026-024-09494-5. Epub 2024 Jun 4.
10
Ataxia-telangiectasia clinical trial landscape and the obstacles to overcome.
Expert Opin Investig Drugs. 2023 Jul-Dec;32(8):693-704. doi: 10.1080/13543784.2023.2249399. Epub 2023 Aug 28.
本文引用的文献
1
Consequences of the delayed diagnosis of ataxia-telangiectasia.
Pediatrics. 1998 Jul;102(1 Pt 1):98-100. doi: 10.1542/peds.102.1.98.
2
Mortality and cancer incidence in 263 patients with ataxia-telangiectasia.
J Natl Cancer Inst. 1986 Jul;77(1):89-92.
Zotero 插件